Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS).

Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S, Klein RS, Shah KV, Sobel JD, Jamieson DJ, Shrestha S.

PLoS One. 2014 Jun 11;9(6):e99109. doi: 10.1371/journal.pone.0099109. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102728.

2.

The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.

Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB.

J Infect Dis. 2007 Sep 15;196(6):887-94. Epub 2007 Aug 7.

PMID:
17703420
3.

Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.

Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk RD.

J Natl Cancer Inst. 2003 Jul 16;95(14):1062-71.

PMID:
12865452
4.

Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.

Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S.

Hum Immunol. 2013 Dec;74(12):1696-700. doi: 10.1016/j.humimm.2013.08.010. Epub 2013 Aug 21.

5.

Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy.

Garbuglia AR, Piselli P, Lapa D, Sias C, Del Nonno F, Baiocchini A, Cimaglia C, Agresta A, Capobianchi MR.

J Clin Virol. 2012 Jun;54(2):141-6. doi: 10.1016/j.jcv.2012.02.013. Epub 2012 Mar 20.

PMID:
22437054
6.

The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.

Louvanto K, Rautava J, Syrjänen K, Grénman S, Syrjänen S.

Clin Microbiol Infect. 2014 Nov;20(11):1167-72. doi: 10.1111/1469-0691.12700. Epub 2014 Jul 12.

7.

Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.

Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, Larsimont D, Delforge M, De Wit S, Clumeck N.

J Infect Dis. 2013 Jun 1;207(11):1723-9. doi: 10.1093/infdis/jit090. Epub 2013 Mar 5.

PMID:
23463709
8.

Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women.

Mbulawa ZZ, Johnson LF, Marais DJ, Gustavsson I, Moodley JR, Coetzee D, Gyllensten U, Williamson AL.

BMC Infect Dis. 2014 Jan 31;14:51. doi: 10.1186/1471-2334-14-51.

9.

Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection.

Sudenga SL, Shrestha S, Macaluso M, Partridge EE, Johanning GL, Piyathilake CJ.

Gynecol Oncol. 2014 Dec;135(3):560-4. doi: 10.1016/j.ygyno.2014.09.015. Epub 2014 Oct 1.

10.

Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age.

Banister CE, Messersmith AR, Cai B, Spiryda LB, Glover SH, Pirisi L, Creek KE.

J Infect Dis. 2015 Jan 1;211(1):100-8. doi: 10.1093/infdis/jiu394. Epub 2014 Jul 15.

11.

Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.

Dalstein V, Merlin S, Bali C, Saunier M, Dachez R, Ronsin C.

J Virol Methods. 2009 Mar;156(1-2):77-83. doi: 10.1016/j.jviromet.2008.11.002. Epub 2008 Dec 17.

PMID:
19041893
12.

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K; DIANAIDS Collaborative Study Group.

Int J STD AIDS. 2003 Jun;14(6):417-25.

PMID:
12816671
13.

Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.

Koshiol J, Schroeder J, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS.

Am J Epidemiol. 2006 Jul 15;164(2):176-83. Epub 2006 Jun 14.

PMID:
16775041
14.

The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa.

Ng'andwe C, Lowe JJ, Richards PJ, Hause L, Wood C, Angeletti PC.

BMC Infect Dis. 2007 Jul 16;7:77.

15.

Uncommon non-oncogenic HPV genotypes, TP53 and MDM2 genes polymorphisms in HIV-infected women in Southern Brazil.

Entiauspe LG, Seixas FK, Nunes EM, Rodrigues FM, Dellagostin OA, Collares T, da Silveira MF.

Braz J Infect Dis. 2014 Nov-Dec;18(6):643-50. doi: 10.1016/j.bjid.2014.07.005. Epub 2014 Sep 1.

16.

Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.

Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G; HIV-HPV Study Group.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):168-75. doi: 10.1097/QAI.0b013e3181938e63.

PMID:
19131892
17.

Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus.

Koshiol JE, Schroeder JC, Jamieson DJ, Marshall SW, Duerr A, Heilig CM, Shah KV, Klein RS, Cu-Uvin S, Schuman P, Celentano D, Smith JS.

Int J Cancer. 2006 Oct 1;119(7):1623-9.

18.

Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.

Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

J Clin Virol. 2013 Dec;58(4):696-702. doi: 10.1016/j.jcv.2013.10.012. Epub 2013 Oct 18.

19.

Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.

Couture MC, Page K, Stein ES, Sansothy N, Sichan K, Kaldor J, Evans JL, Maher L, Palefsky J.

BMC Infect Dis. 2012 Jul 28;12:166. doi: 10.1186/1471-2334-12-166.

20.

HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.

Langley CL, Benga-De E, Critchlow CW, Ndoye I, Mbengue-Ly MD, Kuypers J, Woto-Gaye G, Mboup S, Bergeron C, Holmes KK, Kiviat NB.

AIDS. 1996 Apr;10(4):413-7.

PMID:
8728046

Supplemental Content

Support Center